Menu
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • Quality Assured Service Delivery
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
    • R&D
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
  • FAST Login
  • Easy Setup
  • Find a Centre
  • SMART Portal
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • Quality Assured Service Delivery
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
    • R&D
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
Home | Investors | ASX Announcements | 2011

ASX Announcements 2011

Date Document
12/12/2011 Newsletter
09/12/2011 Patent Application Lodged for MRI Measurement of Fatty Liver
05/12/2011 Resonance Health appoints Middle East distributor
16/11/2011 Results of Meeting
16/11/2011 Managing Director`s Address to Shareholders
31/10/2011 Appendix 4C - quarterly
17/10/2011 Notice of Annual General Meeting/Proxy Form
17/10/2011 Annual Report to shareholders
28/09/2011 Full Year Statutory Accounts
31/08/2011 Preliminary Final Report
08/08/2011 Appendix 3Y
03/08/2011 FDA clearance to market cardiac iron test in USA
01/08/2011 Change in address of office premises
29/07/2011 Appendix 4C - monthly
23/05/2011 RHT Develops Accurate Fatty Liver Diagnostic Test
29/04/2011 Appendix 4C - quarterly
28/03/2011 Presentation at Small Cap Showcase Expo 2011
10/03/2011 Expands Master Service Agreement with Novartis
25/02/2011 Half Yearly Report and Accounts
11/02/2011 RHT signs agreement with Pfizer
31/01/2011 Appendix 4C - quarterly
21/01/2011 RHT Gains Worldwide Exclusive License
18/01/2011 Response to ASX Query re Appendix 3Z
14/01/2011 FerriScan Reimbursement Update
12/01/2011 Final Director`s Interest Notice

 

Investors

  • Business Overview
  • Board and Management Team
  • Share Price
  • ASX Announcements
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
  • ASX subscribe
  • Annual Reports
  • Analyst Coverage
  • R&D
  • Twitter
  • LinkedIn
  • Search
  • © 2018 Resonance Health
  • Disclaimer
  • Privacy
  • Sitemap
Website by ChooseDigital.com.au